Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas.
暂无分享,去创建一个
F. Spyratos | K. Hacène | P. Martin | C. Bouchet | J. Oglobine | A. Gentile | K. Hacéne | Frédérique Spyratos | Pierre-Marie Martin